TC Biopharm () (TCBPW)
0.01
-0.01 (-41.86%)
At close: Jan 15, 2025, 11:17 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -5.91M | -1.31M | -13.58M | -5.46M | -6.07M |
| Depreciation & Amortization | 633.01K | 959.05K | 1.01M | 1.08M | 904.47K |
| Stock-Based Compensation | 444.46K | 1.12M | n/a | 804.71K | 835.79K |
| Other Working Capital | 863.31K | -762.15K | n/a | n/a | n/a |
| Other Non-Cash Items | -7.26M | -15.26M | 7.58M | -1.58M | -2.66M |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 1.54M | -799.65K | -591.62K | 1.73M | 258.05K |
| Operating Cash Flow | -10.54M | -15.29M | -5.58M | -3.43M | -6.73M |
| Capital Expenditures | -110.35K | -240.71K | -20.03K | -34.90K | -2.03M |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -98.44K | -69.48K | -123.19K | -170.09K | -170.06K |
| Investing Cash Flow | -208.79K | -310.20K | -143.22K | -204.99K | -2.20M |
| Debt Repayment | n/a | -2.61M | 6.26M | -415.27K | 135.54K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 4.33M | 17.90M | -21.16K | -53.27K | n/a |
| Financial Cash Flow | 8.52M | 18.65M | 6.53M | 3.43M | 3.27M |
| Net Cash Flow | -2.35M | 3.24M | 818.67K | -208.48K | 956.50K |
| Free Cash Flow | -10.66M | -15.53M | -5.60M | -3.47M | -8.76M |